Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Sep
30
Today In Oncology
Cleveland Clinic to Host Second Annual AI Summit for Health-Care Professionals
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
AI’s Evolving Role in Clinical Care Enterprise-Wide
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo